Q32 Bio
QTTB
53 hedge funds and large institutions have $419M invested in Q32 Bio in 2018 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 15 closing their positions.
267% more capital inflows, than outflows
Capital inflows: $68.3M | Capital outflows: $18.6M
73% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 15
26% more funds holding
Funds holding: 42 → 53 (+11)
20% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 10
6.58% more ownership
Funds ownership: 48.47% → 55.05% (+6.6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$10.6M |
| 2 |
JP Morgan Chase
New York
|
+$10.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$9.3M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.01M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Rock Springs Capital Management
Baltimore,
Maryland
|
-$2.09M |
| 2 |
Jennison Associates
New York
|
-$1.87M |
| 3 |
Goldman Sachs
New York
|
-$1.73M |
| 4 |
Millennium Management
New York
|
-$1.7M |
| 5 |
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$1.62M |
QTTB Hedge Fund Activity: Q2 2018 in Review
53 of the 4,386 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q2 2018, worth a combined $419M — up 25% from $336M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new QTTB positions and 15 closed out — a net gain of 11 holders — while 12 added to existing stakes and 10 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $10.6M. The largest seller was Rock Springs Capital Management, cutting an estimated $2.09M.
- 53 institutional investors held Q32 Bio (QTTB) as of Q2 2018, up from 42 in Q1 2018.
- Funds reported $419M of Q32 Bio stock for Q2 2018, up 25% quarter-over-quarter.
- 26 funds opened new Q32 Bio positions in Q2 2018 and 15 closed out, a net change of +11 holders.
- The largest Q32 Bio buyer in Q2 2018 was BlackRock, an estimated $10.6M added.
- The largest Q32 Bio seller in Q2 2018 was Rock Springs Capital Management, an estimated $2.09M sold.
Based on aggregated 13F filings for Q2 2018.